VFY logo

Vitrafy Life Sciences Limited Stock Price

ASX:VFY Community·AU$105.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

VFY Share Price Performance

AU$0
-1.63 (-100.00%)
AU$0
-1.63 (-100.00%)
Price AU$0

VFY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

Vitrafy Life Sciences Limited Key Details

AU$1.0m

Revenue

AU$0

Cost of Revenue

AU$1.0m

Gross Profit

AU$33.8m

Other Expenses

-AU$32.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.51
100.00%
-3,121.97%
0%
View Full Analysis

About VFY

Founded
2017
Employees
22
CEO
Brenton Michael Owens
WebsiteView website
www.vitrafy.com

Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.

Recent VFY News & Updates

Recent updates

No updates